Popular Articles
Natural Remedies

Editorials, Opinion Pieces React To Kansas Abortion Provider Tiller's Murder
Several newspapers on Wednesday published editorials and opinion pieces responding to the shooting death of Kansas abortion provider George Tiller, who was one of the few physicians in the country providing care for women in need of the procedure later in pregnancy. Summaries appear below.Editorials~ Boston Globe: Although officials are calling Tiller"s murder ""the act of an isolated individual," ... the generalized culture of violence and hate in the antiabortion movement that feeds the fanaticism of disturbed individuals with guns is not so easily explained away," a Globe editorial states. The editorial notes, "Many responsible abortion opponents, including Americans United for Life, condemn the killing," but "other so-called pro-life leaders insist on finding a moral equivalence between Tiller"s murder and abortion." The editorial continues, "Also victimized by Tiller"s murder are the anguished women who have sought late-term abortions because their pregnancies have gone horribly wrong." According to the editorial, the "sad irony" is that these procedures "are not a matter of "choice,"" as the "overwhelming majority of these women desperately wanted their children to be born." It adds, "Tiller"s brave and compassionate care saved the lives of these women and their futures as mothers." In his speech last month at the University of Notre Dame"s commencement ceremony, President Obama "called for people of good will on both sides of the abortion issue to bridge the divide," the editorial states, concluding, "An end to the hateful rhetoric over issues of faith that lead unhinged individuals to murder would be a good place to start" (Boston Globe, 6/2).~ USA Today: Tiller"s "insistence" on continuing to practice, despite protests and threats of violence, "was remarkably courageous," but, "[r]egrettably, threats by antiabortion activists have worked all too well," a USA Today editorial states. According to the Guttmacher Institute, the number of abortion providers has decreased by 40% since a peak in 1982, and 87% of U.S. counties have no provider, forcing many women to travel long distances to obtain care, the editorial says. "Mainstream pro-life groups should not be blamed for the actions of a suspected killer who appears to have lurked in the violent and twisted fringe of the movement," the editorial continues. However, the "braying of cable TV hosts," such as Fox News" Bill O"Reilly, "and activists such as Operation Rescue founder Randall Terry contributes to a climate of intolerance that can encourage deranged individuals," the editorial says. According to USA Today, "Thwarted in legislatures and courts, some antiabortion activists are achieving with intimidation and harassment what they can"t through the political process," but "[r]egardless of personal beliefs about abortion, authorities have an obligation to protect those providing and receiving abortion services, and to prosecute those who harass or threaten them." The editorial concludes that "Tiller"s death will only be compounded if it frightens away more doctors and makes a legal procedure even harder to come by" (USA Today, 6/3).~ Washington Post: Tiller"s death "is a tragedy for his family, his patients and his profession," and "[i]t should serve as a wake-up call that more must be done to ensure that women have access to this legal procedure," a Post editorial states. "It is unclear how this violence has affected decisions by health care providers," according to the editorial. However, it is clear that "the number of places where women can go for abortions has been declining since 1982," and "[v]ery few are performed in hospitals -- a sign that mainline medicine is not living up to its responsibility," the editorial says. The editorial notes that Attorney General Eric Holder "is offering U.S. Marshals Service protection for abortion clinics and the doctors who staff them," concluding, "It"s the right call, but one that underscores the urgency of coming up with better solutions for the delive
generic viagra online
Scientists Investigate Severity And Spread Of New H1N1 Swine Flu Virus
Scientists in the US and the Netherlands discovered what most doctors already suspected: the new H1N1 swine flu virus causes more
News of the day
FDA Requires Labeling Change For Some Drugs Used To Prevent Rejection Of Kidney Transplants
The U.S. Food and Drug Administration said that it will require manufacturers of some immunosuppressant drugs used in kidney (renal) transplantation to update their labeling to reflect an increased risk of infections.
Cardiovascular

Technology To Improve Accuracy Of Ovarian Cancer Diagnosis

Moffitt Cancer Center and Frantz BioMarkers, LLC have signed a license agreement on phospholipid biomarkers of ovarian cancer. Frantz BioMarkers, which has been granted exclusive worldwide rights to Moffitt"s interests in the biomarkers, will pay initiation, developmental milestone and license maintenance fees, and royalties on sales. Moffitt and Frantz BioMarkers will collaborate on ovarian cancer biomarker research, combining use of these licensed markers with lipid markers developed independently by Frantz BioMarkers. Each year, 26,000 women in the United States are diagnosed with ovarian cancer, and 16,000 die of the disease. There is no effective screening tool or method for accurate diagnosis without surgery. Even among symptomatic women, surgery is the only reliable way to distinguish between benign and malignant disease. It is estimated that up to 5 percent of women in the United States will undergo surgery for a suspected ovarian neoplasm. More than two-thirds of women undergoing surgery for suspected ovarian malignancy do not have cancer. The only clinical blood biomarker available for diagnosis is CA125, which is unreliable, especially for accurate diagnosis at an early stage when a cure is feasible. Researchers at Moffitt and Frantz BioMarkers discovered that when CA125 is combined with selected phospholipids, the diagnostic accuracy for early stage ovarian cancer can significantly improve. More than 2,200 women donated blood samples for the research through the Tampa Bay Ovarian Cancer Coalition, a collaborative regional network. Frantz BioMarkers is developing these biomarkers into a clinical diagnostic test. Co-inventors of the technology are Dr. Rebecca Sutphen, director of Clinical Genetics at Moffitt, and Lorelei Davis, Ph.D., and Lian Shan, Ph.D., of Frantz BioMarkers. Michelle Foley H. Lee Moffitt Cancer Center & Research Institute


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):